AbbVie Inc. Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent
AbbVie Inc. (ABBV) reported Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent · last filed 2020-05-08
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for the quarter ending 2020-03-31 was $0.00.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for the quarter ending 2019-12-31 was $0.00.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for the quarter ending 2019-09-30 was $0.00.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for the quarter ending 2019-06-30 was $0.00.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2019 was $0.00.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2018 was $0.00.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2017 was -$8.00M.
- AbbVie Inc. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2016 was -$11.00M, a 150.00% decline from fiscal 2015.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | $0.00 derived: sum of 3 quarters · filed 2020-05-08 | $0.00 derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-02-21 | $0.00 derived: sum of 3 quarters · filed 2020-02-21 | $0.00 10-K · filed 2020-02-21 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | $0.00 derived: sum of 3 quarters · filed 2020-05-08 | $0.00 derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | $0.00 derived: sum of 3 quarters · filed 2020-05-08 | $0.00 derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-02-21 | $0.00 derived: sum of 3 quarters · filed 2020-02-21 | $0.00 10-K · filed 2020-02-21 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | -$14.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | -$14.00M derived: sum of 3 quarters · filed 2020-02-21 | -$10.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-03 | -$14.00M derived: sum of 2 quarters · filed 2020-02-21 | -$10.00M derived: sum of 3 quarters · filed 2020-02-21 | -$7.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$10.00M derived: sum of 2 quarters · filed 2020-02-21 | -$7.00M derived: sum of 3 quarters · filed 2020-02-21 | -$8.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $4.00M 10-Q · filed 2018-11-07 | $7.00M derived: sum of 2 quarters · filed 2018-11-07 | $6.00M 10-Q · filed 2018-11-07 | $2.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $3.00M 10-Q · filed 2018-08-07 | $2.00M 10-Q · filed 2018-08-07 | -$2.00M derived: sum of 3 quarters · filed 2019-02-27 | -$1.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$1.00M 10-Q · filed 2018-05-04 | -$5.00M derived: sum of 2 quarters · filed 2019-02-27 | -$4.00M derived: sum of 3 quarters · filed 2019-02-27 | -$5.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$3.00M derived: sum of 2 quarters · filed 2019-02-27 | -$4.00M derived: sum of 3 quarters · filed 2019-02-27 | -$11.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.00M 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | -$7.00M 10-Q · filed 2017-11-07 | $13.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$1.00M 10-Q · filed 2017-08-07 | -$8.00M 10-Q · filed 2017-08-07 | $12.00M derived: sum of 3 quarters · filed 2018-02-16 | $15.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$7.00M 10-Q · filed 2017-05-05 | $13.00M derived: sum of 2 quarters · filed 2018-02-16 | $16.00M derived: sum of 3 quarters · filed 2018-02-16 | $17.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $23.00M derived: sum of 2 quarters · filed 2018-02-16 | $24.00M derived: sum of 3 quarters · filed 2018-02-16 | $22.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | $3.00M 10-Q · filed 2016-11-07 | $4.00M derived: sum of 2 quarters · filed 2016-11-07 | $2.00M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $1.00M 10-Q · filed 2016-08-05 | $1.00M 10-Q · filed 2016-08-05 | ||
| 2014-12-31 | $1.00M 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-02-21 | |||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | -$6.00M derived: sum of 3 quarters · filed 2015-02-20 | -$19.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | -$6.00M derived: sum of 2 quarters · filed 2015-02-20 | -$19.00M derived: sum of 3 quarters · filed 2015-02-20 | -$13.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | -$19.00M derived: sum of 2 quarters · filed 2015-02-20 | -$13.00M derived: sum of 3 quarters · filed 2015-02-20 | -$15.00M 10-K · filed 2015-02-20 |
| 2012-09-30 | -$13.00M 10-Q · filed 2013-11-12 | -$7.00M derived: sum of 2 quarters · filed 2013-11-12 | -$9.00M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $6.00M 10-Q · filed 2013-08-09 | $4.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | -$2.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $10.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |